WallStreetZenWallStreetZen

NASDAQ: IBRX
Immunitybio Inc Stock Ownership - Who owns Immunitybio?

Insider buying vs selling

Have Immunitybio Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Richard AdcockCEO President2024-02-0543,165$4.04
$174.39kSell
Regan J. LauerChief Accounting Officer2024-01-3113,470$3.36
$45.26kSell
Barry J. SimonDirector2024-01-3122,094$3.36
$74.24kSell
David C. SachsChief Financial Officer2024-01-3126,835$3.36
$90.17kSell
Richard AdcockCEO President2023-12-3117,096$5.02
$85.82kSell
David C. SachsChief Financial Officer2023-12-3110,511$5.02
$52.77kSell
Patrick SoonshiongExecutive Chairman Global Chief Scientific and Medical Officer2023-09-11129,127,017$1.29
$166.57MBuy
Patrick SoonshiongExecutive Chairman Global Chief Scientific and Medical Officer2023-09-1132,606,985$1.29
$42.06MBuy
Patrick SoonshiongExecutive Chairman Global Chief Scientific and Medical Officer2023-09-1147,557,934$1.29
$61.35MBuy
Michael D. BlaszykDirector2023-06-0548,000$2.77
$132.96kBuy

1 of 2

IBRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IBRX insiders and whales buy or sell their stock.

IBRX Shareholders

What type of owners hold Immunitybio Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Patrick Soonshiong7.04%47,437,011$379.02MInsider
Vanguard Group Inc1.98%13,328,525$106.49MInstitution
Blackrock Inc1.59%10,710,179$85.57MInstitution
State Street Corp1.41%9,470,909$75.67MInstitution
Geode Capital Management LLC0.50%3,379,464$27.00MInstitution
Barry J. Simon0.47%3,144,904$25.13MInsider
Credit Suisse Ag 10.23%1,529,908$12.22MInstitution
Jpmorgan Chase Co0.21%1,422,212$11.36MInstitution
Northern Trust Corp0.20%1,357,059$10.84MInstitution
Goldman Sachs Group Inc0.19%1,278,638$10.22MInstitution

1 of 3

IBRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IBRX8.50%7.94%Net BuyingNet Selling
APLS74.88%25.12%Net BuyingNet Selling
BPMC81.64%18.36%Net SellingNet Selling
HALO78.21%21.79%Net SellingNet Selling
IONS96.31%3.69%Net SellingNet Selling

Immunitybio Stock Ownership FAQ

Who owns Immunitybio?

Immunitybio (NASDAQ: IBRX) is owned by 8.50% institutional shareholders, 7.94% Immunitybio insiders, and 83.56% retail investors. Patrick Soonshiong is the largest individual Immunitybio shareholder, owning 47.44M shares representing 7.04% of the company. Patrick Soonshiong's Immunitybio shares are currently valued at $379.02M.

If you're new to stock investing, here's how to buy Immunitybio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.